Hospital Infantil Dr. Robert Reid Cabral Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2006
NCT00386542
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (2)

auriclosene (1 trial)

inactivated influenza vaccine (1 trial)

Drugs in Other Trials (1)

hydroxyurea (hydrea) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Impetigo (Phase 2)

Influenza, Human (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 3